ACS prostate screening guidance sets testing intervals by age and risk
The American Cancer Society advises annual PSA tests from age 45 for Black men and biennial testing from age 50 for average-risk men.

The American Cancer Society released updated prostate cancer screening guidance on Thursday 12 November, advising Black men aged 45 to 69 to have a prostate-specific antigen, or PSA, blood test each year. Men at average risk aged 50 to 69 are advised to have PSA testing every two years.
According to the American Cancer Society, United States research shows Black men have a 67% higher incidence of prostate cancer and nearly twice the mortality rate of White men. The society said its guidance is not a formally announced change to Sint Maarten healthcare policy, but can inform discussions with healthcare providers about screening, family history and individual risk.
Read the full story166 more words
The annual recommendation also applies to non-Black men with a strong family history, including men whose father, brother or son was diagnosed before age 65, or men with multiple first-degree relatives diagnosed at any age. Non-Black men with one first-degree relative diagnosed at 65 or older are advised to start testing at 45, every two years through age 69.
The American Cancer Society said men aged 70 to 74 should decide on continued screening with their doctors, based on health, life expectancy, personal preferences and the possible benefits and risks. Routine screening is generally not recommended from age 75, although exceptionally healthy men aged 75 to 79 may consider it after consulting a doctor. The society does not recommend screening for men aged 80 or older, or for people with a life expectancy of less than 10 years.
The society last updated its recommendations in 2010. It said newer research and improvements in diagnostic procedures support screening’s role in reducing prostate cancer deaths and advanced diagnoses.
File photo: Andrey Butko / Wikimedia Commons · CC BY-SA 3.0 · cropped, SXM Today mark added



